EZH2 is a key component of hepatoblastoma tumor cell growth.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2026 · 1 min read
In brief
In brief
This research investigates EZH2's role in hepatoblastoma tumor growth through both canonical histone methylation and noncanonical protein interactions. The study explores EZH2 as a therapeutic target in this pediatric liver malignancy, examining mechanisms beyond its traditional epigenetic function.
Written by the GCMD Library team from the article.
Statements in this article
Enhancer of zeste homolog 2 (EZH2) catalyzes the trimethylation of histone H3 at lysine 27 via the polycomb recessive complex 2 (PRC2).
EZH2 plays a time-specific role in normal fetal liver development.
EZH2 is overexpressed in hepatoblastoma.
EZH2 can promote tumorigenesis via a noncanonical, PRC2-independent mechanism through proto-oncogenic direct protein interaction.